Octapharma to build $1.5 billion state-of-the-art critical care manufacturing facility in Rock Hill, SC
On Jul. 29, 2026, Octapharma, the largest privately owned and independent plasma fractionator in the world, has formally announced plans to establish its first-ever United States-based manufacturing and…